Jacqueline Mock

558 total citations
19 papers, 306 citations indexed

About

Jacqueline Mock is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Jacqueline Mock has authored 19 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Immunology. Recurrent topics in Jacqueline Mock's work include CAR-T cell therapy research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immunotherapy and Immune Responses (7 papers). Jacqueline Mock is often cited by papers focused on CAR-T cell therapy research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immunotherapy and Immune Responses (7 papers). Jacqueline Mock collaborates with scholars based in Switzerland, Italy and Netherlands. Jacqueline Mock's co-authors include Dario Neri, Samuele Cazzamalli, Aureliano Zana, Jacopo Millul, Christian Pellegrino, Sheila Dakhel Plaza, Alessandra Villa, Etienne J. Donckèle, Gabriele Bassi and Andreas Gloger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Jacqueline Mock

17 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacqueline Mock Switzerland 10 226 118 93 84 50 19 306
Haley du Bois United States 6 180 0.8× 17 0.1× 103 1.1× 144 1.7× 37 0.7× 9 320
Robin Maximilian Awad Belgium 10 192 0.8× 110 0.9× 117 1.3× 151 1.8× 7 0.1× 17 335
Hanna Maar Germany 8 125 0.6× 44 0.4× 106 1.1× 62 0.7× 15 0.3× 16 235
Alice Bakker United States 3 54 0.2× 167 1.4× 264 2.8× 61 0.7× 14 0.3× 8 349
Ikram El Zaoui Switzerland 8 95 0.4× 44 0.4× 119 1.3× 82 1.0× 12 0.2× 8 314
Clemens Achmüller Austria 6 41 0.2× 56 0.5× 305 3.3× 49 0.6× 10 0.2× 9 392
Tero Kivel� Finland 7 79 0.3× 66 0.6× 121 1.3× 43 0.5× 18 0.4× 7 281
Elke Gerlach Germany 8 92 0.4× 60 0.5× 239 2.6× 143 1.7× 13 0.3× 12 344
Heinke Conrad Germany 12 269 1.2× 44 0.4× 150 1.6× 238 2.8× 4 0.1× 16 460

Countries citing papers authored by Jacqueline Mock

Since Specialization
Citations

This map shows the geographic impact of Jacqueline Mock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Mock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Mock more than expected).

Fields of papers citing papers by Jacqueline Mock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Mock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Mock. The network helps show where Jacqueline Mock may publish in the future.

Co-authorship network of co-authors of Jacqueline Mock

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline Mock. A scholar is included among the top collaborators of Jacqueline Mock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline Mock. Jacqueline Mock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Müller, Marco, Tony Georgiev, Jacqueline Mock, et al.. (2025). Small Organic Carbonic Anhydrase IX Ligands from DNA-Encoded Chemical Libraries for Tumor-Targeted Delivery of Radionuclides. Journal of the American Chemical Society. 147(21). 18230–18239. 7 indexed citations
2.
Gilardoni, Ettore, Jacqueline Mock, Frauke Seehusen, et al.. (2024). A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO Molecular Medicine. 16(4). 904–926. 4 indexed citations
3.
Galbiati, Andrea, et al.. (2024). Preclinical Evaluation of177Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors. Journal of Nuclear Medicine. 65(10). 1604–1610. 11 indexed citations
4.
Pellegrino, Christian, Sheila Dakhel Plaza, Alessandra Villa, et al.. (2023). Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties. mAbs. 15(1). 2220839–2220839. 4 indexed citations
5.
Gilardoni, Ettore, Jacqueline Mock, Tobias Weiß, et al.. (2023). An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics. 15(2). 377–377. 6 indexed citations
6.
Galbiati, Andrea, Ettore Gilardoni, Aureliano Zana, et al.. (2023). Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics. Journal of Nuclear Medicine. 64(12). 1934–1940. 10 indexed citations
7.
Gilardoni, Ettore, Jacqueline Mock, Samuele Cazzamalli, et al.. (2023). Abstract 5744: Decreasing toxicity of immunocytokines by transient and selective inhibition of their intracellular signaling activation. Cancer Research. 83(7_Supplement). 5744–5744.
8.
Mortensen, Michael R., et al.. (2023). Site-Specific Chemical Modification of a Cytokine Mimic for Small Molecule-Based Tumor Targeting. Bioconjugate Chemistry. 34(8). 1374–1379.
9.
Galbiati, Andrea, Aureliano Zana, Jacopo Millul, et al.. (2022). A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake. Journal of Nuclear Medicine. 63(12). 1852–1858. 44 indexed citations
10.
Mock, Jacqueline, et al.. (2021). A Novel Antibody–IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis. Molecular Cancer Therapeutics. 20(5). 859–871. 19 indexed citations
11.
Millul, Jacopo, Gabriele Bassi, Jacqueline Mock, et al.. (2021). An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications. Proceedings of the National Academy of Sciences. 118(16). 103 indexed citations
12.
Catalano, Marco, et al.. (2021). Cancer therapy in mice using a pure population of CD8+ T cell specific to the AH1 tumor rejection antigen. Cancer Immunology Immunotherapy. 70(11). 3183–3197. 10 indexed citations
13.
Plaza, Sheila Dakhel, Christian Lizak, Mattia Matasci, et al.. (2021). An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease. International Journal of Molecular Sciences. 22(18). 10020–10020. 10 indexed citations
14.
Myburgh, Renier, Norman F. Russkamp, Adrian G. Guggisberg, et al.. (2021). A Bispecific Antibody Targeting CD117 and CD3 Enables T Cell Mediated Killing of CD117-Expressing Healthy and Malignant Hematopoietic Cells. Blood. 138(Supplement 1). 2354–2354. 1 indexed citations
15.
Mock, Jacqueline, et al.. (2021). Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression. mAbs. 13(1). 113–115. 5 indexed citations
16.
Mock, Jacqueline, et al.. (2020). An engineered 4-1BBL fusion protein with “activity on demand”. Proceedings of the National Academy of Sciences. 117(50). 31780–31788. 20 indexed citations
17.
Mock, Jacqueline, Christian Pellegrino, & Dario Neri. (2020). A universal reporter cell line for bioactivity evaluation of engineered cytokine products. Scientific Reports. 10(1). 3234–3234. 12 indexed citations
18.
Mortensen, Michael R., et al.. (2020). Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors. Oncotarget. 11(44). 3972–3983. 4 indexed citations
19.
Tytgat, Hanne L. P., Chia‐Wei Lin, Mikail D. Levasseur, et al.. (2019). Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies. Nature Communications. 10(1). 5403–5403. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haley du Bois Breakdown of academic impact, for papers by Robin Maximilian Awad Breakdown of academic impact, for papers by Hanna Maar Breakdown of academic impact, for papers by Alice Bakker Breakdown of academic impact, for papers by Ikram El Zaoui Breakdown of academic impact, for papers by Clemens Achmüller Breakdown of academic impact, for papers by Tero Kivel� Breakdown of academic impact, for papers by Elke Gerlach Breakdown of academic impact, for papers by Heinke Conrad
Rankless by CCL
2026